NeuroAge Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years in Advance
November 25, 2024 21:01 ET | NeuroAge Therapeutics
NeuroAge Therapeutics launches the NeuroAge Test, a cutting-edge tool predicting dementia risk 30 years early to optimize brain health
DiamiR Announces SBIR Phase I Award for Aging Program
June 07, 2016 08:02 ET | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - June 07, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that the National Institute on Aging (NIA) of the...